Joseph J. Schildkraut

Joseph J. Schildkraut publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Joseph J. Schildkraut sits on this spectrum.

Joseph J. Schildkraut D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph J. Schildkraut sits on this spectrum.

Best Publications

• THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE

  Unknown

  3476
  Citations

• Biogenic Amines and Emotion

  Unknown

  869
  Citations

• Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite

  Saul M. Schanberg;Joseph J. Schildkraut;George R. Breese;Irwin J. Kopin

  527
  Citations

• Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock

  Geraldine Cassens;Mark Roffman;Alvin Kuruc;Paul J. Orsulak

  387
  Citations

• Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.

  Joseph J. Schildkraut;Paul J. Orsulak;Alan F. Schatzberg;Jon E. Gudeman

  291
  Citations

• Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

  Joseph J. Schildkraut

  278
  Citations

• Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

  A I Green;S V Zimmet;R D Strous;J J Schildkraut

  245
  Citations

• Catecholamine metabolism in affective disorders—III

  Unknown

  240
  Citations

• The effects of psychoactive drugs on norepinephrine-3H metabolism in brain

  S.M. Schanberg;J.J. Schildkraut;I.J. Kopin

  209
  Citations

• Some Biochemical Correlates of Panic Attacks with Agoraphobia and Their Response to a New Treatment

  David V. Sheehan;James H. Coleman;David J. Greenblatt;Kenneth J. Jones

  197
  Citations

• Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study.

  Joseph Biederman;David B. Herzog;Timothy M. Rivinus;Gordon P. Harper

  192
  Citations

• Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline

  Alan F. Schatzberg;Alan F. Schatzberg;Alan H. Rosenbaum;Paul J. Orsulak;Paul J. Orsulak;William A. Rohde;William A. Rohde

  189
  Citations

• Norepinephrine Metabolism and Drugs Used in the Affective Disorders: A Possible Mechanism of Action

  Joseph J. Schildkraut;Saul M. Schanberg;George R. Breese;Irwin J. Kopin

  187
  Citations

• Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion

  Robert Watson;Ernest Hartmann;Joseph J. Schildkraut

  186
  Citations

• Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine.

  Joseph J. Schildkraut;Andrew Winokur;Clarence W. Applegate

  179
  Citations

• Neuropsychopharmacology and the Affective Disorders

  Unknown

  167
  Citations

• The effects of lithium ion on H3 -norepinephrine metabolism in brain

  Joseph J. Schildkraut;Saul M. Schanberg;Irwin J. Kopin

  163
  Citations

• The effects of lithium salts on the turnover and metabolism of norepinephrine in rat brain

  Joseph J. Schildkraut;Mayada A. Logue;George A. Dodge

  158
  Citations

• THE EFFECTS OF PENTOBARBITAL ON THE FATE OF INTRACISTERNALLY ADMINISTERED NOREPINEPHRINE-H3

  Saul M. Schanberg;Joseph J. Schildkraut;Irwin J. Kopin

  154
  Citations

• Catecholamine metabolism in affective disorders: I.

  Unknown

  135
  Citations